|
UGT8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65559999043552E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01649999528775E-09 |
| Normal-vs-Stage2 |
3.5381999996531E-08 |
| Normal-vs-Stage3 |
5.64080004927803E-10 |
| Normal-vs-Stage4 |
2.88049999996876E-06 |
| Stage1-vs-Stage2 |
1.889620E-01 |
| Stage1-vs-Stage3 |
7.004400E-01 |
| Stage1-vs-Stage4 |
1.286200E-01 |
| Stage2-vs-Stage3 |
1.377200E-01 |
| Stage2-vs-Stage4 |
6.549000E-01 |
| Stage3-vs-Stage4 |
7.408100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11079997924912E-09 |
| Normal-vs-AfricanAmerican |
1.49629997281409E-09 |
| Normal-vs-Asian |
8.14630030099295E-10 |
| Caucasian-vs-AfricanAmerican |
7.915800E-01 |
| Caucasian-vs-Asian |
7.493900E-02 |
| AfricanAmerican-vs-Asian |
2.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.50259981813417E-10 |
| Normal-vs-Female |
1.13289999603694E-08 |
| Male-vs-Female |
2.161800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.93079999053236E-09 |
| Normal-vs-Extreme_Weight |
5.01899966032227E-10 |
| Normal-vs-Obese |
2.63190003124691E-09 |
| Normal-vs-Extreme_Obese |
1.45930000305938E-08 |
| Normal_Weight-vs-Extreme_Weight |
2.770000E-01 |
| Normal_Weight-vs-Obese |
7.917000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.988400E-01 |
| Extreme_Weight-vs-Obese |
3.451000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.004000E-01 |
| Obese-vs-Extreme_Obese |
9.152400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.28540000000366E-05 |
| Normal-vs-Age(41-60Yrs) |
2.03450001290406E-09 |
| Normal-vs-Age(61-80Yrs) |
8.36819946670175E-10 |
| Normal-vs-Age(81-100Yrs) |
3.64180019474247E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.812360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.339230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.582300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.181600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.259400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.517200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.65770002963961E-10 |
| Normal-VS-Type2 PRCC |
2.85510004527367E-09 |
| Normal-VS-KIRP CIMP |
4.358500E-03 |
| Normal-VS-Unclassified PRCC |
1.69979996744729E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.399600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.609900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.356600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.608100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.292800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.562400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.90830051550029E-10 |
| Normal-vs-N1 |
2.06990002915575E-09 |
| Normal-vs-N2 |
1.587520E-02 |
| N0-vs-N1 |
5.652800E-01 |
| N0-vs-N2 |
5.376600E-01 |
| N1-vs-N2 |
8.285600E-01 |
|
|
